Studies have shown an altered expression of miRNAs in insulin-sensitive tissues from obese or overweight individuals and patients with T2D, suggesting a potential role of these small RNA molecules in the complications associated with MetS and T2D [7,8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.